Who are Editas Medicine's decision-makers?
Editas Medicine's official leadership and governance pages are the safest source for named executives.
- Primary buyers
- Finance, procurement, IT, security, operations, legal, and business leadership
- Company status
- Public company; Nasdaq: EDIT
- HQ
- Cambridge, United States
- Category
- Genome editing company
- Decision style
- Public-company buying committee
- Best source
- Official leadership or IR page
- Editas Medicine executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
- Editas Medicine finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, capital allocation, and budget discipline.
- Editas Medicine operations or technology leadershipOperations, product, technology, security, or commercial leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operating-improvement purchases.
Who leads Editas Medicine?
Editas Medicine's named leaders should be verified directly on the company's official leadership, governance, or investor-relations page.
Who owns buying decisions at Editas Medicine?
The buying committee depends on the offer and usually spans finance, procurement, legal, IT/security, and the business owner.
How should sellers map the account?
Start with headquarters and public leadership, then map functional owners by product area, job posts, filings, partner announcements, and investor materials.
As of June 2026.Sources:Editas Medicine official websiteEditas Medicine investor relations or company newsBuiltWith public technology profile
Editas Medicine — frequently asked questions
Read the full Editas Medicine profile
More on Editas Medicine
Who are Editas Medicine's decision-makers — other companies
Revenue work. On autopilot.
Start Free TrialBuilt for revenue teams who care about quality.